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The use of a new PCR based method for the diagnosis of malaria in the Malaria Reference 
Laboratory has promoted an increase in suspected malaria cases from the Spanish Hospitals. From 
August 1997 to July 1998, a total of 192 whole blood samples and 71 sera were received from the 
hospitals of the Spanish National Health System. Most of the patients came from West-Central 
African countries (85%).  
This molecular method showed more sensitivity and specificity in comparison to microscopy 
detecting 12.4% more positive samples than microscopy and 13% of  mixed infections undetectable 
by Giemsa stain.  
P.falciparum was the main specie detected with 68% of the total positive malaria cases 
following of P.malariae (29%), P.vivax (14%) and P.ovale (7%), including mixed infections in all 
cases.  
Until now no tolerant vivax-strain had been reported from West-Central Africa. PCR 
detected two vivax-infections primaquine tolerant strains from this region and a falciparum-
infection by blood transfusion in a Spanish woman. 
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Introduction 
Malaria has a major place among the endemic tropical diseases. Malaria risk of varying 
degrees existed in 100 countries and territories [1]. The increase of tourism, the non governmental 
collaboration with developing countries and mainly migration by wars and socio-economic factors 
have caused an increase of malaria imported cases in immigrants and travellers returning from 
endemic areas to malaria-free countries. In Spain malaria was eradicated in 1962, the last year of 
reported cases. Since 1960s all malaria infections reported have been imported cases. From 1985 to 
1992 the number of malaria imported cases per year ranged between 100 and 150 and, actually have 
progressively increased up to an average of 230 cases per year, but just the 30-40% are reported [2]. 
WHO recommends the surveillance of all imported malaria cases and positive action by  European 
laboratories in the indirect surveillance of the spreading of malaria resistance in developing 
countries.  
The incorporation of the molecular tools for the diagnosis of parasite infections has allowed 
an increase of sensitivity in the detection of human malaria parasites in blood. The malaria 
laboratory of the National Centre of Microbiology in Spain is using a semi-nested multiplex malaria 
PCR (SnM-PCR) capable of detecting the four human malaria species in blood samples. Nowadays, 
various molecular methods based on the amplification of DNA have been developed for the 
detection of the malaria infections in humans [3-8], but only one of these can detect the four species 
of Plasmodium [6-7], using five PCR reactions in contrast to the two steps of the SnM-PCR [9]. 
Moreover, the present method includes an individual positive control in each sample to prevent 
false negatives.  
The aim of this work was: a) carry out the study of the malaria surveillance in Spain, 
including origin of infections, Plasmodium species involved and possible susceptibility to 
traditional treatments and b) to compare the SnM-PCR with the traditional Giemsa stain diagnosis 
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method, in order to improve the accuracy and the sensitivity of the diagnosis using this new 
methodology and, the following of the patients after treatment of clinic episodes in order to evaluate 
the effectiveness of antimalarial drugs.  
 
Material and Methods 
The study was carried out in the Parasitology Department of the National Centre of 
Microbiology in Madrid from August 1997 to July 1998. A total of 192 whole blood samples and 71 
sera were received from the National Health System (INSALUD) from 168 patients with at least a 
symptom compatible with clinic malaria. In several cases different samples were sent from the same 
patients for surveillance of effectiveness of the treatment. 
108 patients (64%) correspond to semi-immune patients from malaria endemic countries. 59 
patients (35%) were non-immune Spanish travellers, who come back after having visited some 
endemic malaria countries, and one patient was a old Spanish woman, which never travel overseas. 
 The last endemic malaria country visited for the patients before coming back to Spain was 
in 141 cases (84%) a West or Central African country (126 cases from Equatorial Guinea, former 
Spanish colony), 14  cases (8%) from Asia (mainly from India) and the resting 12 cases (7%) were 
from Eastern Africa and Central America. 
Whole blood samples were collected, thick and thin blood smears stained with 10% Giemsa 
(Merck, Germany) and examined microscopically by two technicians. Immuno Fluorescence Assay 
(IFA) tests were performed in our laboratory from cultures of the 3D7 clone from a strain of 
P.falciparum.  
The extraction method of DNA (from 3µl of blood) was carried out using the Chelex method  
with minor modifications [9,10].  
 Detection and identification of malaria species were simultaneously performed using a 
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sequence of two (semi-nested multiplex) PCR reactions [9], and the size of products were estimated 
from 2% agarose gel electrophoresis using ethidium bromide staining . 
 The PCR reaction mix for the first reaction consisted of 10 mM Tris-HCl (pH 8.3), 50 mM 
KCl, 1.5 mM MgCl2, 0.001% (W/V) gelatin, 1% glycerol, 200 µM each of dNTPs, the PCR 
primers, 2.5 units AmpliTaq DNA polymerase (Perkin-Elmer, NJ, USA) and 41.1 µl of template 
DNA in a final volume of 50 µl. The concentration of primers were 25 pmoles for UNR (5’- 
GACGGTA TCTGATCGTCTT-3’), 25 pmoles for PLF (5’-AGTGTGTATCAATCGAGTTT-3’) 
and 1.25 pmoles for HUF (5’-GAGCCGCCTGGATACCG-3’). This first reaction is expected to 
yield two products: the first is a band of 231 bp from UNR-HUF produced by the amplification of 
human ssrDNA (the positive control for each individual sample) and a second band of 783-821 bp 
(depending on the Plasmodium species) from UNR-PLF that should detect the presence of any 
malaria species, although this fragment is not visible on the agarose gel. In the multiplex-PCR the 
reaction mix consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2, 0.001% (W/V) 
gelatin, 1% glycerol, 200 µM each of dNTPs, the PCR primers, one unit AmpliTaq DNA 
polymerase (Perkin-Elmer) and  4 µl of a dilution 4/1000 of the PCR product of the first reaction as 
template in a final volume of 25µl. The concentration of primers, empirically obtained, was 25 
pmoles for PLF, 3.12 pmoles for MAR (5’-GCCCTCCAATTGCCTTCT-3’), 15 pmoles for FAR 
(5’-AGTTCC CCTAGAATAGTTACA-3’), 6.25 pmoles for OVR (5’-
GCATAAGGAATGCAAAGAACAG-3’) and 2.5 pmoles  for VIR (5’-AGGACTTCCAAGC 
CGAAG-3’). Infections with different human Plasmodium species yields products of different sizes. 
A band of 269 bp indicates P.malariae infection; a band of 395bp shows P.falciparum infection; a 
band of 436 bp suggests a P.ovale infection and a band of 499 bp indicates a P.vivax infection. 
Mixed infections would show all the appropriate bands. 
For both reactions a 2400 GeneAmp PCR system (Perkin-Elmer, USA) thermal cycler was used, 
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beginning with five minutes denaturation at 94ºC, followed by (first reaction) 40 cycles with 45 
seconds at 94ºC, 45 seconds at 62ºC, and 60 seconds at 72ºC or (multiplex-PCR reaction) 35 cycles 
with 20 seconds at 94ºC, 20 seconds at 62ºC and 30 seconds at 72ºC. The final cycle was followed 
by an extension time of ten minutes at 72ºC. 
 
Results 
89 patients (53%) were malaria positive by the SnM-PCR while, just, 70 patients (41.7%) 
were malaria positive by microscopy. SnM-PCR proved capable of detecting 11.3% of infected 
patients that were negatives on thin and thick films by microscopy. A total of 24 new blood samples 
from several diagnosed patients were sent, after total or partial treatment, to confirm the 
effectiveness of the treatment. SnM-PCR, still, show the presence of malaria parasites in 11 cases 
(45.8%) while the microscopy just detected a malaria  infection in 6 cases (25%), 20.8% less that 
the amplification of DNA by PCR. The SnM-PCR detected 100 (52%) malaria infections of the 
total of processed samples (192), while microscopy detected 76 (39.6%) positive samples, 
indicating 12.4% more of detected malaria infections than by microscopy (Table 1).  
By social groups, 61 patients (56.5%) born in endemic countries were malaria is an endemic 
disease were positive by SnM-PCR while microscopy just detected 51 infected individuals (47%). 
Twenty seven (45.7%) non-immune Spanish travellers were positive by the SnM-PCR, while the 
microscopy detected 19 (32,2%) patients with malaria asexual parasites in blood. The old Spanish 
woman was positive by the SnM-PCR and ten days later was positive also by IFA test but was 
negative by microscopy (Table 1).  
The most represented Plasmodium specie in the samples, considering the SnM-PCR results, 
was P.falciparum (68%), which is present in 59 samples as a single infection and in other 9 as a 
mixed infection. P.malariae with 16 positive samples (20%) plus 5 mixed infection samples 
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resulted the second Plasmodium specie more often detected followed of P.vivax (14%) and P.ovale 
(7%), which are present in 10 and 6 samples respectively as single infections and 4 and 1 
respectively as mixed infections. The SnM-PCR was able to identify 9 mixed infections while the 
microscopy just detected two ( 13% more of mixed infections by PCR than the microscopy). All the 
mixed infections detected were from people who have born in endemic countries except a triple 
infection from a Spanish missionary who lived in West-Africa, Asia and South-America in the last 
twenty years (table 2). 
In 135 out of 192 blood samples the SnM-PCR and the microscopy show the same results, 
including a triple infection. However, in 36 samples the SnM-PCR detected malaria species not 
identified by microscopy. Out of 116 microscopically negative samples 30 were SnM-PCR positive 
and in other 6 cases SnM-PCR identified a second Plasmodium specie in the sample. When 
different results of PCR and microscopy where obtained, the thin and thick films were carefully re-
examined resolving 84% of all discrepancies in favour of the SnM-PCR (table 3). 
The only discrepancy resolved in favour of the microscopy was a microscopically mixed 
infection P.falciparum plus P.ovale from which only P.falciparum was detected by the SnM-PCR. 
In this case, the positive control on the first reaction was partially inhibited, probably, due to the fact 
that the sample was clotted blood. In 9 cases the discrepancy remained unresolved but probably due 
to a higher sensitivity of the SnM-PCR method than to a missed diagnosis (table 3). 
According to expected results IFA serological tests presented discrepancies with the data 
obtained by microscopy or by SnM-PCR. Just 30 (42%) or 43 (60.5%) samples in comparison to 
microscopy or to SnM-PCR respectively show equal positive or negative results. Six samples (8%) 
with titre higher than 1/10240 and 8 (11%) with titres higher than 1/5120 were negatives by SnM-
PCR and microscopy while 2 (3%) samples IFA negatives were positive by SnM-PCR and 
microscopy.   
8  
New samples (24) from several patients (14) previously diagnosed by SnM-PCR were sent 
to confirm the total elimination of the parasite in blood or because the patient still had malaria 
symptoms after partial or total treatment.  
Two brothers born in Equatorial Guinea, a boy and a girl (4 and 5 years of age respectively), 
were analysed by microscopy and SnM-PCR few days after they came back to Spain. Both children 
presented a falciparum-infection by microscopy beginning standard treatment with seven days of 
quinine sulphate and clindamicine. PCR determined in both (girl and boy) a mixed infection by P. 
falciparum and P. vivax in our laboratory. On this date both were treated with quinine sulphate at 
guideline of 10 days. Once finished the first treatment with quinine sulphate (10 days) and 
clindamicine is received a new sample of both children determining by SnM-PCR a single 
falciparum-infection in the boy being parasite negative the girl. This result demonstrates the failure 
of the treatment with quinine sulphate at guideline of ten days, begining a new treatment with 
quinine during 10 days and no receiving treatment with primaquine diphosphate. Forty days later 
two new samples of the two children were received in our laboratory resulting both vivax-malaria 
infections by PCR and the blood of the girl was also diagnosed like vivax-infection by microscopy. 
This result indicates a first relapse caused by the hepatic hypnozoites. The childrens were treated 
with primaquine diphosphate (0.25 mg/kg of weight during 14 days) after determination of 
negativity to G6PD-deficiency by filter paper blood spot fluorescence test. Three months later a new 
sample resulted a vivax-infection in the boy being malaria negative infection in the girl, resulting a 
new relapse caused by a tolerant strain to primaquine diphosphate. New guideline with primaquine 
diphosphate was used for treatment of this vivax-infection (0.35 mg/kg body weight /14 days) joint 
to a new treatment with quinine sulphate of seven days. Three months later is received a new blood 
sample of the boy resulting a falciparum-infection by microscopy and a falciparum+vivax-infection 
by SnM-PCR. Then, was carried out a medical prescription with mefloquine (15 mg per body 
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weight on twice) plus a new treatment with a higher dose of primaquine diphosphate (0.5 mg/kg of 
body weight/14 days) . After treatment, clinical cure and no presence of parasites in blood was 
confirmed by microscopy and SnM-PCR. At present, surveillance of this patient is being carried out 
for possible relapses. 
A sample from a 63 years old Spanish woman who presented symptoms of clinical malaria 
but never travelled outside the country was confirmed as P.falciparum infection by the SnM-PCR. 
The woman was infected by blood transfusion from a patient with previous history of malaria 
infection seven months early. The serum of the patient previous to the transfusion resulted negative 
by the IFA test (<1/80). New serum twenty days after transfusion resulted positive at titre 1/2560 




In 1997 the Malaria Reference Laboratory was created under the direction of the 
Parasitology Department of the Instituto de Salud Carlos III in Spain, with the main objective of 
carrying out the surveillance of the malaria imported cases suspected in the National Health System 
of Spain. The creation of this initiative has been well accepted by the Hospitals and Centres of the 
National System of Health in the country and has promoted a great perception by the departments of 
infectious diseases as well as the medical personnel in primary health care. One year later, more 
than 50% of malaria cases detected in Spain were diagnosed in this laboratory. 
The main source of infection detected in Spain indicates to West-Central Africa as the major 
risk area for acquiring the malaria infections. Among the West-Central African samples studied,  the 
majority of them were from Equatorial Guinea, mainly due to the high rate of immigration into 
Spain, as well as governmental and no governmental collaboration in the development of the 
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country joint to the business relations between Spain and this former Spanish colony. The high 
number of malaria infections from this country is explained by the high rates of malaria prevalence 
(80% of children under 10 years of age present parasites in blood) [11].  West-Central Africa 
corresponds to meso-hyperendemic areas where the socio-economic status of the population causes 
great difficulties in the implementation of the control activities by the National  Malaria 
Programmes [1]. 
Seventy eight percent of the malaria positive patients show Plasmodium falciparum as 
source of the disease, and it could be imported from any endemic malaria region. Plasmodium 
malariae (20%) was  the second specie involved following of Plasmodium vivax from Asian and 
Central American regions. Plasmodium ovale was restricted to West-Central Africa region. IFA 
serological test is just a good diagnosis method for people who have never been previously in 
contact with the infection, because semi-immune individuals present a acquired immunity after a 
first or repeat contact with the parasite producing IgG malaria antibodies that are present in the 
serum when no infection is present.   
The SnM-PCR used in the laboratory shows to be a good tool in the detection and correct 
malaria diagnosis, in all cases, after correct treatment the malaria symptoms of the patients 
disappear, proving the accuracy of the diagnosis. Besides, PCR increased the detection of malaria 
parasites as regards to microscopy, allowing an increase in the patency level of parasite detection. 
12.4% of negative cases by microscopy were positive samples when diagnosed by SnM-PCR and 
other 13% were diagnossed as double infections whereas the microscopy just detected single 
infections. This fact could be due to low parasitaemias in semi-immune patients due to acquired 
immunity and in no-immune patients determined for the prophylactic protection with malarial 
drugs.  
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Only two mixed infections could be detected by microscopy whereas SnM-PCR detected 8 
mixed infections undetected microscopically, but missed one, probably for inhibition of the PCR 
reaction. Four of these mixed infections presented P. falciparum plus P. vivax or P.ovale species, 
indicating the importance of the determination of the Plasmodium specie or species involved in the 
infection for the specific treatment of the hepatic hypnozoites. This fact joint to the severity  and 
development of the disease depending on the Plasmodium species involved.  
Two mixed infections of P. falciparum plus P. vivax  confirmed the presence of a possible 
focus of Plasmodoum vivax in Equatorial Guinea [9], a West-Central African country with a 
majority population without the Duffy receptor, necessary for the P.vivax invasion of the red blood 
cell and opens news perspectives about of the consolidation of the transmission of this parasite in 
West and Central African populations. Plasmodium vivax infections were detected in samples from 
mulatto children. As the Fy allele does not produce neither Fya nor Fyb antigens, Fy a-b- phenotype is 
the major allele in Blacks (frequency: 0.7 to 1), and it is possible that a focus exists  composed of 
white and mulatto individuals which maintain the transmission. Future studies on a possible 
correlation between the expressed Fy allele and the infection by P. vivax may explain the infections 
detected in Equatorial Guinea [12-13].  
The occurrence of relapses of P.vivax after primaquine therapy would be assumed to be the 
most reliable indication of resistance. In this case failure to 1st (0.25 mg/kg/14 days) and 2nd (0.35 
mg/kg/14 days) treatment, at different and increasing therapeutic doses, was demonstrated by the 
presence of P. vivax relapse detected by SnM-PCR accompanied by clinic features. The time of the 
appearance of the relapses (each 2,5-3 months) could be indicative of a strain type Cheson from 
Southeast Asia [14 ]. A few reports shown the presence of relapses in Africa indicating the Cheson 
pattern, but always on East-Africa not in West-Central Africa. Higher dose of primaquine was 
administered on the 3rd relapse (0.5mg/Kg/14 days) preventing the appearance until now of new 
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relapses. Higher doses of primaquine have been used by several authors for the treatment of 
hypnozoites in liver [15-16]. Until now, primaquine tolerant strains have been described in 
Southeast Asia [17-18], Western Pacific and Central America [19-20] but only sporadic cases of 
failure have been described in Eastern Africa [21]. It must be noted that falciparum-infection also 
was resistant to standard treatment, as seen after the third relapse of the disease where P. falciparum 
was also detected, even if the patient had not left Spanish territory in the meantime. This fact could 
be explained for low parasitaemias presented by semi-immune indiciduals which can persist during 
several months until appearance of a new clinical episode. The presence of P. vivax infection is very 
rare and the P. ovale infection rates are quite low in Equatorial Guinea, thus, the primaquine is not 
the current treatment choice in a case of clinic malaria. Besides, this fact is increased by the high 
rate of G6PD-deficient people because enzyme deficient people and pregnant women cannot use 
this antimalarial drug. This could suggest that this mixed infection (P. falciparum plus P. vivax) 
could have its origin in some Asiatic strains, imported into Equatorial Guinea. In Asia, prevalence 
of tolerant strains for both Plasmodium species is quite high, whereas in West-Central Africa a 
double resistance in the same individual had not been detected before [18]. 
Furthermore, there are other three cases of P.falciparum tolerant to quinine, two from 
Equatorial Guinea and the third from Pakistan. The percentage of tolerant strains to quinine is still 
very low 7.3%, in comparison to resistance at chloroquine and mefloquine, but the number of 
resistant strains is increasing [1].   
A case of malaria by transfusion was detected by SnM-PCR and confirmed by IFA test in a 
63 year old woman without any history of travel to endemic areas. Changes in population 
demographics, immigration, as well as increase in travel to endemic areas could contribute to 
increase the number of prospective blood donors who could be infected by malaria. PCR has been 
used in the screening of blood donors demonstrating more sensitivity than microscopy [22]. In 
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developed countries, serology is the most common technique to detect anti-malarial antibodies in 
the screening of blood donors. In the future, SnM-PCR will allow an increase in the sensitivity of 
the conventional diagnosis, avoiding infections by blood transfusion. PCR together to serology 
would be the most effective combination  to detect malaria parasites in blood donors individuals 
[23].  
Moreover, the appearance of a possible autochthonous case of P. vivax in Italy [24], the 
increase of malaria cases in North Africa [25] and the high rate of migration through Spain from 
Subsaharian individuals indicates the relevance to develop a system of surveillance capable of 
studying not only the clinical cases, but also the actual role of the Anopheles vectors and its capacity 
in malaria transmission in former Spanish endemic areas, in order to control the possible re-
introduction of the malaria disease.  
Some recent epidemics have been linked to climatic change in conjunction with socio-
economic degradation, wars and collapse of health services. The risk for reintroduction of malaria in 
eradicated countries is minimal [1] due to socio-economic development and the high level of the 
Health System but a system of surveillance of re-emergence diseases like malaria due be established 
in Spain.  
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 Table 1. Patients, samples and results by social groups and totals by SnM-PCR and microscopy. 
 
  Patients  Method    Positives      Negatives   Repeated* Method   Positives   Negatives    Total     Method    Positives     Negatives 
                        samples               samples 
 
  PCR     61 (56.5%)  47 (43.5%)   PCR 6 (66.6%)   3 (33.3%)  PCR    67 (57.3%)   50 (42.7%)  
Immigrants 108        9             117 
  Micro.  51  (47%)  57 (53%)    Micro. 4 (44.4%)   5 (56.6%)  Micro.    55 (47%)   62 (53%) 
  
  PCR     27 (45.7%)  32 (54.3%)    PCR  5 (35.7%)   9 (64.2%)  PCR      32 (43.8%)   41 (56.2%) 
Travellers  59     14         73 
  Micro.  19 (32.2%)  40 (67.8%)    Micro.    2 (14.3%) 12 (85.7%)  Micro.    21 (28.8%)   52 (71.2%) 
 
  PCR       1 (100%)    0 (0%)   PCR   0 (0%)   1 (100%)  PCR        1 (50%)     1 (50%) 
Spanish    1        1           2 
native  Micro.    0 (0%)    1 (100%)   Micro.  0 (0%)   1 (100%)  Micro.      0 (0%)     2 (100%) 
  
  PCR     89 (53%)  79 (47%)   PCR       11 (45.8%)13 (54.2%)  PCR   100 (52%)   92 (48%) 
Totals 168      24       192 
  Micro.  70 (41.7%)     98 (58.3%)   Micro  6 (25%) 18 (75%)  Micro.    76 (39.6%) 116 (60.4%) 
 
*Samples received for the control of the effectiveness of the treatment with antimalarial drugs
  
Table 2. Results of SnM-PCR versus microscopy. Neg = Negative; F = P.falciparum; M = 
P.malariae;  O = P.ovale;  V = P.vivax;  Psp. = Plasmodium specie. 
 
         Neg F M O V FM FO     FV    FMV Totals PCR 
    
   Neg  86 20   8 1  1         116 
   F    1 29  1  2  3        36 
   M     1   7 1  1          10 
   O     3              3 
   V       9             9 
   FO     1                1 
   FMV         1         1 
   Psp.    5   8   1   1 1         16 
    
   Totals 92 59 16 6 10 4 1 3 1     192 
                          Microscopy
  
Table 3. Discrepancies between SnM-PCR and microscopy before and after re-examination of the 
slides. = equal results. <> discrepancy on Plasmodium specie. -/+ Negative result by microscopy 
and single infection by PCR. +/++ Single infection by microscopy and double infection by PCR. ?/+ 
Undetermined Plasmodium infection by microscopy and determined single infection by PCR. ?/++ 
Undetermined  Plasmodium infection by microscopy and determined double infection by PCR. ++/+ 
Double infection by microscopy and single infection by PCR. +/- Single infection by microscopy 
and negative result  by PCR. 
 
 
  =  <> -/+ +/++ ?/+ ?/++ ++/+ +/- 
examination  135  3 30    6   9    2    1  6 
re-examination 183  0   5    2   0    1    1  0 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
